Miloš Grujić, Co-Chair of Career Development Working Group at European School of Oncology, shared a post on X:
“Our new paper is out in Cancers!
Ultra-low-dose RT (4 Gy/2 fr) achieves excellent control and safety in ocular adnexal lymphoma.
Big thanks to my amazing co-authors.”
Title: Clinical Outcomes and Safety of Ultra-Low-Dose Radiotherapy for Ocular Adnexal Lymphoma: A Systematic Review
Journal: Cancers
Authors: Miloš Grujić, Stanislav Volchenkov, Aidos Akhmetali, Marija Živković Radojević, Neda Milosavljević, Katarina Janković, Katarina Krasić, Milica Mihajlović, Mohamed Shelan, Luca Nicosia, Mladen Marinković
More posts featuring Miloš Grujić on OncoDaily.